However, the precise relationship between IFN-β treatment and depressive symptoms in MS has not yet been definitively established, hindered in part by the partial overlap of MS symptoms with those of depression (Goeb et al., 2006). This evidence concerns the gene IFNB1 and myeloid sarcoma.